Skip to main content
Log in

“The Uncertain and Unpredictable”: Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP)—Three Cases

  • Case report
  • Published:
Indian Journal of Gynecologic Oncology Aims and scope Submit manuscript

Abstract

Smooth muscle tumors of uncertain malignant potential (STUMP) are rare tumors, which cannot be unequivocally diagnosed as benign or malignant and carry recurrence risk of 8.7–11% including delayed recurrence. The literature on STUMP is scarce and consensus regarding gold standard treatment and follow-up is lacking. The aim of this study was to identify the patients diagnosed as STUMP at VPS Lakeshore Hospital and Research Centre and to study the patient characteristics and outcome. All patients who underwent hysterectomy from 2012 January to 2016 December were identified, among which three patients were diagnosed as STUMP in the final histopathology report. Case files and reports were reviewed. Patient characteristics and follow-up data were analyzed. Two patients underwent open abdominal hysterectomy. One underwent total laparoscopic hysterectomy. All three patients were premenopausal. Two patients presented with menorrhagia and one patient with irregular cycles. One patient had undergone modified radical mastectomy for carcinoma breast and was on tamoxifen. One patient succumbed to death due to recurrence within 1 year of surgery, and two patients are asymptomatic and on follow-up (follow-up period 3 and 2 years). Difficulties in diagnosis of STUMP, unpredictability of recurrence and literature review are discussed. Patients with diagnosis of STUMP should be informed regarding risk of recurrence including delayed recurrence. The patients require closer and long-term follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kempson RL. Sarcomas and related neoplasms. In: Norris HJ, Hertig AT, Abell MR, editors. The uterus. Baltimore: Williams & Wilkins; 1973.

    Google Scholar 

  2. Rajaram S, Chitratara K, Maheswari A. Uterine cancer: diagnosis and treatment, vol. 11. New Delhi: Springer India; 2015. p. 128–9.

    Book  Google Scholar 

  3. Dall’Asta A, Gizzo S, Musaro A, Quaranta M, Noventa M, Migliavacca C, et al. Uterine smooth muscle tumor of uncertain malignant potential (STUMP): pathology, follow up and recurrence. Int J Clin Exp Pathol. 2014;7(11):8136–42.

    PubMed  PubMed Central  Google Scholar 

  4. Kurman RJ, Carcanjiu ML, Simon HC, Young RH. WHO classification of tumors of female reproductive organs. 4th ed. Lyon: IARC Press; 2014.

    Google Scholar 

  5. Ip PP, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol. 2010;17:91–112.

    Article  PubMed  Google Scholar 

  6. Ip PP, Cheung AN. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential. Best Pract Res Clin Obstet Gynaecol. 2011;25:691–704.

    Article  PubMed  Google Scholar 

  7. White MP, Rahimi S, Garely A, Buhl A, Dean RM. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): review of pathophysiology, classification, diagnosis, treatment, and surveillance. J Healthc Commun. 2017;2:40.

    Google Scholar 

  8. Ryo T, Katsunori K, Mina A, Koji N, Nobumichi N, Masayuki S, et al. Preoperative ultrasound guided biopsy of 63 uterine tumors having high signal intensity upon T2-weighed magnetic resonance imaging. Int J Gynecol Cancer. 2014;24(6):1042–7.

    Article  Google Scholar 

  9. Hanley KZ, Birdsong GG, Mosunjac MB. Recent developments in surgical pathology of the uterine corpus. Arch Pathol Lab Med. 2017;141:58–541.

    Article  Google Scholar 

  10. Deodhar KK, Goyal P, Rekhi B, Menon S, Maheshwari A, et al. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation. Indian J Pathol Microbiol. 2011;54:706–11.

    Article  PubMed  Google Scholar 

  11. Mayerhofer K, Lozanov P, Bodner K, Bonder-Adler B, Kimberger O, Czerwenka K. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS). Acta Obstet Gynecol Scand. 2004;83(11):1085–8.

    Article  PubMed  Google Scholar 

  12. Liang Y, Zhang X, Chen X, Lu W. Diagnostic value of progesterone receptor, p16, p53, and pHH3 expression in uterine atypical leiomyoma. Int J Clin Exp Pathol. 2015;8:7196–202.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Atkins KA, Arronte N, Darus CJ, Rice LW. The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol. 2008;32(1):98–102.

    Article  PubMed  Google Scholar 

  14. Gannon BR, Manduch M, Childs TJ. Differential immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants. Int J Gynecol Pathol. 2008;27(1):68–73.

    Article  PubMed  Google Scholar 

  15. Campbell JE, Knudtson JF, Valente PT, Robinson RD, Kost ER. Successful pregnancy following myomectomy for uterine smooth muscle tumor of uncertain malignant potential: a case report and review of the literature. Gynecol Oncol Rep. 2016;15:1–3.

    Article  PubMed  Google Scholar 

  16. Peeters N, Hulsbosch S, Ballaux F, Baekelandt J. Uterine smooth muscle tumors of uncertain malignant potential: analysis of diagnoses and therapies illustrated by two case reports. Eur J Gynecol Oncol. 2016;37(3):367–73.

    CAS  Google Scholar 

  17. Ip PP, Cheung AN, Clement PB. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2009;33(7):992–1005.

    Article  PubMed  Google Scholar 

  18. Gizzo S, Di Gangi S, Bertocco A, Noventa M, Fagherazzi S, Ancona E, et al. Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits—systematic review of literature. Review article. Reprod Sci. 2014;21:423–31.

    Article  CAS  PubMed  Google Scholar 

  19. Conconi D, Chiappa V, Perego P, Redaelli S, Bovo G, Lavitrano M, et al. Potential role of BCL-2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential. Oncol Rep. 2017;37(1):41–7.

    Article  PubMed  Google Scholar 

  20. Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009;113(3):324–6.

    Article  PubMed  Google Scholar 

  21. Ng JS, Han A, Chew SH, Low J. A clinicopathologic study of uterine smooth muscle tumours of uncertain malignant potential (STUMP). Ann Acad Med Singap. 2010;39:625–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepa Joseph.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joseph, D., Chitrathara, K. “The Uncertain and Unpredictable”: Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP)—Three Cases. Indian J Gynecol Oncolog 16, 40 (2018). https://doi.org/10.1007/s40944-018-0212-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40944-018-0212-y

Keywords

Navigation